@article{52e6bb0ee6f6495ca00a34cc8d056e21,
title = "Characterization of lobulated fibers in limb girdle muscular dystrophy type 2A by gene expression profiling",
abstract = "Limb girdle muscular dystrophy type 2A (LGMD2A) is caused by mutations in CAPN3, which encodes an intracellular cysteine protease. To elucidate the fundamental molecular changes that may be responsible for the pathological features of LGMD2A, we employed cDNA microarray analysis. We divided LGMD2A muscles into two groups according to specific pathological features: an early-stage group characterized by the presence of active necrosis and a regeneration process and a later-stage group characterized by the presence of lobulated fibers. After comparing the gene expression profiles of the two groups of LGMD2A muscles with control muscles, we identified 29 genes whose mRNA expression profiles were specifically altered in muscles with lobulated fibers. Interestingly, this group included genes that encode actin filament binding and regulatory proteins, such as gelsolin, PDZ and LIM domain 3 (PDLIM3) and troponin I1. Western blot analysis confirmed the upregulation of these proteins. From these results, we propose that abnormal increased expression of actin filament binding proteins may contribute to the changes of the intra-myofiber structures, observed in lobulated fibers in LGMD2A.",
keywords = "Actin filament, Calpain 3, Limb girdle muscular dystrophy type 2A, Lobulated fiber, Myofibril, cDNA microarray",
author = "Yoko Keira and Satoru Noguchi and Rumi Kurokawa and Masako Fujita and Narihiro Minami and Hayashi, {Yukiko K.} and Takashi Kato and Ichizo Nishino",
note = "Funding Information: The authors thank Drs. I. Nonaka, M. Malicdan and M. Astejada (National Center of Neurology and Psychiatry) for helpful discussions and their critical comments on the manuscript, and Ms. F. Uematsu for her technical assistance. This study was supported by the “Research on Psychiatric and Neurological Diseases and Mental Health” from Health and Labour Sciences Research Grants; the “Research on Health Sciences focusing on Drug Innovation” from the Japanese Health Sciences Foundation; the “Research Grant (16B-2, 17A-10) for Nervous and Mental Disorders” from the Ministry of Health, Labour and Welfare; and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). Copyright: Copyright 2009 Elsevier B.V., All rights reserved.",
year = "2007",
month = apr,
doi = "10.1016/j.neures.2006.12.010",
language = "English",
volume = "57",
pages = "513--521",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "4",
}